March 10, 2020 / 7:41 AM / 25 days ago

BRIEF-Molmed FY Net Loss Narrows To EUR 0.4 Mln

March 10 (Reuters) - Molecular Medicine SpA:

* REPORTED ON MONDAY FY TOTAL OPERATING REVENUES EUR 36.3 MLN VS EUR 29.9 MLN

* FY NET LOSS OF EUR 427,000 VS LOSS OF EUR 4.1 MLN YEAR AGO

* FY POSITIVE EBITDA EUR 3.3 MLN VS NEGATIVE EBITDA OF EUR 2.2 MLN YEAR AGO

* DUE TO COVID-19 EMERGENCY, CO SETTLED THROUGH AD HOC CRISIS COMMITTEE NEW PROCEDURES AIMED AT MINIMIZING RISK OF CONTAGION FOR EMPLOYEES AND AT SUPPORTING BUSINESS CONTINUITY

Source text for Eikon:

Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below